Skip to content
Home/Companies/Healthcare/Gamamabs Pharma
GP

Gamamabs Pharma

Healthcare·France·Active·5yr hold

Gamamabs Pharma is a healthcare company, headquartered in France.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Gamamabs Pharma?

Gamamabs Pharma is currently owned by Irdi Capital-Investissement through IRDI Impulsion (2021 vintage), since 2021. Across its history, Gamamabs Pharma has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Irdi Capital-Investissement
Most recent investor
Irdi Capital-Investissement
IRDI Impulsion · 2021 · Buyout
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by iXO Private Equity and Irdi Capital-Investissement since 2013.
Co-invest · 2 holders · 2013 · present
iXO Private Equity
iXO Private EquityActive
2013 · present · FIP APL 2013 · 2013 · Growth
MOIC
–
Irdi Capital-Investissement
Irdi Capital-InvestissementActive
2021 · present · IRDI Impulsion · 2021 · Buyout
MOIC
–

More from IRDI Impulsion

Other portfolio companies in the same fund.

ThIA Sante Mentale
Active
MedTechFrance· 2026
GA Smart Building
Active
IndustrialsFrance· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings